| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $953,444 ) |
| | 2024 | 2024 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | SB1HL174394 | Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft | 001 | 1 | NIH | 9/5/2024 | -$953,444 |
| | 2024 | 2024 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | SB1HL174394 | Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft | 001 | 1 | NIH | 9/5/2024 | $953,444 |
| | 2024 | 2024 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | SB1HL174394 | Commercial and Regulatory Development of an Enhanced Performance Hemodialysis Access Graft | 000 | 1 | NIH | 4/15/2024 | $953,444 |
| | 2024 | 2021 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 6 | NIH | 1/26/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | HEALIONICS | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R43DK122883 | Infection Resistant Hemodialysis Access Graft | 000 | 1 | NIH | 10/31/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $984,472 ) |
| | 2021 | 2021 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 001 | 6 | NIH | 6/30/2021 | $984,472 |
| | 2021 | 2020 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 5 | NIH | 10/26/2020 | $0 |
| | 2021 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK116380 | Clinical Study of an Extended-Patency Dialysis Access Graft | 000 | 1 | NIH | 3/10/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $997,847 ) |
| | 2020 | 2020 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 5 | NIH | 6/25/2020 | $997,847 |
|
| Issue Date FY: 2019 ( Subtotal = $1,223,448 ) |
| | 2019 | 2019 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 4 | NIH | 9/11/2019 | $998,633 |
| | 2019 | 2019 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R43DK122883 | Infection Resistant Hemodialysis Access Graft | 000 | 1 | NIH | 8/28/2019 | $224,815 |
| | 2019 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK103512 | Biointegrating Dialysis Access Graft with Self Stabilizing Flow | 000 | 4 | NIH | 12/28/2018 | $0 |
| | 2019 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK116380 | Clinical Study of an Extended-Patency Dialysis Access Graft | 000 | 1 | NIH | 7/22/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 3 | NIH | 12/5/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $863,459 ) |
| | 2017 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK116380 | Clinical Study of an Extended-Patency Dialysis Access Graft | 001 | 1 | NIH | 9/15/2017 | -$440,339 |
| | 2017 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 3 | NIH | 3/22/2017 | $142,446 |
| | 2017 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK103512 | Biointegrating Dialysis Access Graft with Self Stabilizing Flow | 000 | 4 | NIH | 8/7/2017 | $280,674 |
| | 2017 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK116380 | Clinical Study of an Extended-Patency Dialysis Access Graft | 000 | 1 | NIH | 9/14/2017 | $440,339 |
| | 2017 | 2017 | HEALIONICS CORPORATION | 2121 N 35TH ST | SEATTLE | WA | 98103-9103 | KING | USA | R44DK116380 | Clinical Study of an Extended-Patency Dialysis Access Graft | 002 | 1 | NIH | 9/18/2017 | $440,339 |
|
| Issue Date FY: 2016 ( Subtotal = $1,229,235 ) |
| | 2016 | 2016 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 2 | NIH | 3/31/2016 | $595,657 |
| | 2016 | 2016 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44DK103512 | Biointegrating Dialysis Access Graft with Self Stabilizing Flow | 000 | 3 | NIH | 7/21/2016 | $633,578 |
|
| Issue Date FY: 2015 ( Subtotal = $1,160,635 ) |
| | 2015 | 2015 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44DK103512 | Biointegrating Dialysis Access Graft with Self Stabilizing Flow | 000 | 2 | NIH | 9/9/2015 | $581,096 |
| | 2015 | 2015 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44HL126256 | Product and Regulatory Development of a Needle-Free Hemodialysis Access Port | 000 | 1 | NIH | 3/9/2015 | $579,539 |
|
| Issue Date FY: 2014 ( Subtotal = $431,039 ) |
| | 2014 | 2014 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R43EY023889 | Fibrosis-Resistant Bleb-Free Gaucoma Implant | 000 | 1 | NIH | 4/24/2014 | $206,540 |
| | 2014 | 2014 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R43DK103512 | Vascular Grafts for Needle Free Dialysis Access Devices. | 000 | 1 | NIH | 9/4/2014 | $224,499 |
|
| Issue Date FY: 2013 ( Subtotal = $461,247 ) |
| | 2013 | 2013 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44GM093697 | ANTI-INFECTIVE DERMAL INTEGRATION SLEEVES FOR NEEDLE FREE DIALYSIS ACCESS DEVICES | 000 | 3 | NIH | 8/14/2013 | $461,247 |
|
| Issue Date FY: 2012 ( Subtotal = $447,918 ) |
| | 2012 | 2012 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R44GM093697 | ANTI-INFECTIVE DERMAL INTEGRATION SLEEVES FOR NEEDLE FREE DIALYSIS ACCESS DEVICES | 000 | 2 | NIH | 9/3/2012 | $447,918 |
|
| Issue Date FY: 2010 ( Subtotal = $199,765 ) |
| | 2010 | 2010 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R43GM093697 | DERMAL INTEGRATION SLEEVE TO REDUCE EXIT SITE INFECTIONS. | 000 | 1 | NIH | 7/16/2010 | $199,765 |
|
| Issue Date FY: 2009 ( Subtotal = $116,418 ) |
| | 2009 | 2009 | HEALIONICS CORPORATION | 14787 NE 95th Street | Redmond | WA | 98052-2557 | KING | USA | R41EY019795 | ARTIFICIAL CORNEA USING NEW BIOMATERIALS | 000 | 1 | NIH | 9/25/2009 | $116,418 |
|
|
